Chancery OKs Shareholder Deal On $5.2B NPS-Shire Sale
A settlement in a class action challenge to the $5.2 billion sale of NPS Pharmaceuticals Inc. to Shire PLC survived a run through Delaware Chancery Court's new Trulia precedent gantlet on...To view the full article, register now.
Already a subscriber? Click here to view full article